Editorial
Meet the Team

Epidemiology of Acute Respiratory Tract Infections (ARI) among Children Under Five Years Old Attending Tikirit General Teaching Hospital

Serum Lipid Levels in Tehranian people

Foot abnormalities in diabetics: prevalence and predictors in Basrha

Herbal Treatment Usage Frequency, Types and Preferences in Turkey

The pattern of Interpersonal Relationship in University students in Persian culture

Health Care System in Pakistan

The Eyes of The Truth - Part 2

Comparative study of local infiltration of bupivacaine and parenteral administration of diclofenac sodium for post tonsillectomy pain in adults

Progressive Sensorineural Hearing Loss and it’s Relation with Normal Tension Glaucoma

Ten minute consultation: Otalgia

Integrative Medicine Educational CD ROM

 

 


Dr Abdulrazak Abyad
MD,MPH, AGSF
Editorial office:
Abyad Medical Center & Middle East Longevity Institute
Azmi Street, Abdo Center,
PO BOX 618
Tripoli, Lebanon

Phone: (961) 6-443684
Fax:     (961) 6-443685
Email:
aabyad@cyberia.net.lb

 
 

Lesley Pocock
medi+WORLD International
572 Burwood Road,
Hawthorn 3122
AUSTRALIA
Emai
l
: lesleypocock

 


Progressive Sensorineural Hearing Loss and Its Relationship with Normal Tension Glaucoma

 
Authors:

Dr. ADNAN. A. AL-JAYOUSI MD

CORRESPONDENCE

P.O.BOX 540088
CODE 11937
AMMAN - JORDAN
e-mail : Adnan_Aljayousi@yahoo.com


ABSTRACT

Objectives: The aim of this study was to evaluate the association between progressive sensorineural hearing loss and normal tension glaucoma.

Materials and methods: This prospective study was conducted in South Shouna Hospital (Ministry of Health- Jordan) during the period between 2003 - 2005. 26 patients attending an ophthalmology clinic and diagnosed to have normal tension glaucoma were referred to the ENT clinic. Ophthalmologic examination included Snellen's visual acuity testing, anterior segment examination via slit lamp, and posterior segment examination after mydriasis via indirect ophthalmoscope, Goldmann's applanation tonometry to measure intraocular pressure, and visual field assessment via Goldmann's perimeter. In the ENT clinic, audiograms, stapedial thresholds and otoacoustic emissions were obtained. Serological testing of antiphospholipids antibodies were done for all patients. The results were compared with two control groups: one had other types of glaucoma, and the other was normal people.

Results: 18 normal tension glaucoma patients (75%) had sensorineural hearing loss. Elevated antiphospholipid antibody concentrations were more frequent in patients with normal tension glaucoma and hearing loss compared with normal tension glaucoma patients with normacusis. There was no association between primary open angle glaucoma, hearing loss and antiphospholipid antibody. Pseudoexfoliation was associated with hearing loss but not with antiphospholipid antibodies.

Conclusions: The association between hearing loss, normal tension glaucoma and antiphospholipid antibody indicates that they are part of autoimmune systemic process.

Keywords: Progressive sensorineural hearing loss, normal tension glaucoma, antiphospholipid antibodies, and autoimmune diseases.


INTRODUCTION

In recent years, the understanding of development and progression of glaucomatous optic nerve damage has changed. There is accumulating evidence for a multifactorial pathogenesis of glaucomatous optic neuropathy. Besides an elevated intraocular pressure, there is special emphasis on cardiovascular and haematological risk factors and also on genetic and immunological aspects 1-3. Recently, Kremmer et al 4 found elevated levels of a subgroup of antiphospholipid antibodies in patients with normal tension glaucoma (NTG) compared to patients with primary open angle glaucoma (POAG) and age matched healthy controls. These findings may be interpreted as a sign for a generalised disease.

Although the pathogenesis of progressive sensorineural hearing loss (PSHL) often remains unclear some research activities have focused on the role of autoantibodies against antigens in the inner ear. This concept was introduced by Reinhardt 5 and is supported by the fact that hearing loss is associated with different autoimmune diseases such as Cogan syndrome, rheumatoid arthritis, Sjögren syndrome, and Behçet's disease 6-8.

Hisashi et al 9 were the first to demonstrate an association between progressive sensorineural hearing loss in patients with lupus erythematosus and antiphospholipid antibodies. They proposed that in patients with lupus erythematosus these antibodies are causative for thrombosis of the labyrinth leading to progressive sensorineural hearing loss.

Phospholipids are constituents of all membranes and are divided in many subspecies such as phosphatidylserine (APSA). It has been theorised that APSA can be generated by any pathological conditions shifting phosphatidylserine from the inner membrane leaflets to the external membrane leaflets of cells 10. This shift is the beginning of the apoptotic mechanism and leads to cell destruction and ischemia in endothelial cells 11. This permits a number of phospholipid binding proteins to be presented to the immune system in unique antigenic conformations, giving rise to antibody production.
The aim of this study was to investigate a possible coincidence between NTG, PSHL and the association to APSA.

 
MATERIALS AND METHODS

This prospective study was conducted in South Shouna Hospital during the period between 2003 - 2005. 26 patients attending ophthalmology clinic and diagnosed as normal tension glaucoma (typical optic disc and visual field damage and intraocular pressure below 21 mmHg) were referred to the ENT clinic. Ophthalmologic examination included Snellen's visual acuity testing, anterior segment examination via slit lamp, and posterior segment examination after mydriasis via indirect ophthalmoscope, Goldmann's applanation tonometry to measure intraocular pressure, and visual field assessment via Goldmann's perimeter. In ENT clinic, audiograms, stapedial thresholds and otoacoustic emissions were obtained.

Hearing loss was compared to previously established hearing thresholds in patients with normal hearing and presbyacusis. Presbyacusis was defined as hearing loss of high frequencies in elderly people whereas PSHL was age independent. Serological testing of antiphospholipids antibodies were done for all patients. APSA level of >15 U/ml was considered elevated.

RESULTS

The mean age of patients with NTG was 64.8 years; 15 females and 9 males (Table 1). 18 normal tension glaucoma patients (75%) had sensorineural hearing loss: 10 (41.7%) were pathological and 8 (33.3%) had presbyacusis (Table 2). Elevated antiphospholipids antibodies concentrations were more frequent in patients with normal tension glaucoma and hearing loss compared with normal tension glaucoma patients with normacusis (Table 3) or other types of glaucoma. Among the other types of glaucoma, primary open angle glaucoma was seen in 10 patients and pseudoexfoliation glaucoma in 8 patients.

DISCUSSION

In the past few years it was shown that autoimmune phenomena are associated with hearing loss. Namedrop et al 12 found a correlation between sudden hearing loss and systemic lupus erythematosus. Moreover, progressive hearing loss may be associated with increased autoantibody levels: Tomato et al 7 were able to demonstrate an increased concentration of IgG anticardiolipin antibodies in 30% of patients with Sjögren's syndrome and sensorineural hearing loss.

In principle, two different entities of autoantibodies were found to be associated with glaucoma: autoantibodies against specific proteins of the retina and the optic nerve 13-14 or against more common antigens 15-16 such as extractable nuclear antigens, small heat shock proteins and serum antibodies against neuron specific enolase.

Interestingly, Shokoohi et al 17 reported on elevated antiphospholipid antibodies in NTG and POAG patients. APSA are a subgroup of antiphospholipid antibodies which are one of the hallmarks of the antiphospholipid syndrome. APSA may be important because of their binding specificity to phosphatidylserine molecules which become accessible during apoptosis, which in turn may lead to local thrombosis.

Interestingly, a higher prevalence of antiphosphatidylserine antibodies was seen in NTG patients with hearing loss in comparison to NTG patients with normacusis. This finding suggests a similar pathological pathway as a sign for generalised disease. The increase of the same antibody entity in patients suffering from both, NTG and PSHL may indicate an association with similar systemic autoimmune processes.

Patients with presbyacusis or PSHL showed a small difference compared to patients with normacusis, suggesting that some patients with presbyacusis also have elevated antiphosphatidylserine antibodies. This is not surprising because antiphospholipid antibodies increase with age. The smaller occurrence of hearing loss compared to normal tension glaucoma might be explained by the fact that the terminal vessel pathway in the eye seems to be more vulnerable to blood supply disturbances or patients are more sensitive to the sense of vision than to hearing. It has been shown that apoptosis can be induced by antiphosphatidylserine antibodies, which results in occlusion of small vessels by thromboemboli and finally leads to disturbance of the microcirculation in the inner ear and eye.

Pseudoexfoliative glaucoma was associated with PSHL but with almost similar APSA level with normal people of same age group. This may be explained by the fact that Pseudoexfoliation is considered as a systemic disease affecting many organs in the body 18.

The association between hearing loss, normal tension glaucoma and antiphospholipid antibody indicates that they are part of autoimmune systemic process. Based on these findings all patients with NTG or significant hearing loss and elevated levels of antibodies against phosphatidylserine should have further ophthalmological or otological work up


Table 1. Patient distribution according to age and sex

Category Mean age (years) Males Females
NTG 64.8 9 15
Other glaucoma 67.3 13 11

Normal

66.5 12 12
Total 66.2 44 38

 

Table 2. Progressive sensorineural hearing loss in different types of glaucoma

Category Pathological PSHL Category Presbyacusis
NTG 10 (41.7%) 8 (33.7%)
POAG 3 (12.5%) 8 (33.7%)

Pseudoexfoliation

8 (33.7%) 7 (29.2%)
Normal 2 (8.3%) 9 (37.5%)

 

Table 3. Antiphospholipid antibodies in different types of glaucoma in patients with PHSL and in normacusis

Category Mean APSA (U/ml) in PSHL Mean APSA in presbyacusis Mean APSA in normacusis
NTG 32.4 27.3 22.1
POAG 16.9 13.2 9.8
Pseudoexfoliation 15.4 15.3 11.3
Normal 14.8 14.4 10.2

< back to text

REFERENCES
1. Durance SM, Sweeney VP, Morgan RW, et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmology 1973; 89:457-65.
2. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21:359-93.
3. Grunwald JE, Piltz J, Hariprasad SM, et al. Optic nerve blood flow in glaucoma: effect of systemic hypertension. Am J Ophthalmology 1999; 127:516-22.
4. Kremmer S, Kreuzfelder E, Klein R, et al. Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin Exp Immunol 2001;125:211-15.
5. Reinhardt E. Plötzliche Hörstörungen, auf beiden Seiten gleichzeitig auftretend oder nacheinander auftretend. Laryngo-Rhino-Otol 1958;37:1-5.
6. Hughes GB, Barna BP, Kinney SE, et al. Clinical diagnosis of immune inner-ear disease. Laryngoscope 1988;98:251-3.
7. Tomato B, Casoli P, Parmeggiani A. Hearing loss in the Sjogren syndrome. Ann Intern Med 1997;126:450-3.
8. Eichhorn A, Kirch W. Sicca-Symptomatik und Hörverlust beim Behcet's Syndrom. Dtsch Med Wochenschr 1998;123:663-6.
9. Hisashi K, Komune S, Taira T, et al. Anticardiolipin antibody-induced sudden profound sensorineural hearing loss. Am J Otolaryngol 1993;14:275-7.
 
10. Bevers EM, Confurius P, Dekkers DWC, et al. Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling. Lupus 1998;7 (Suppl 2) :S126-31.
11. Lockwood CJ, Rand JH. The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 1994;49:432-41.
12. Namedrop M, Spiera H. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies. J Rheumatol 1998;25:589-92.
13. Ikeda Y, Ohguro H, Maruyama I. Two cases of primary open angle glaucoma with serum autoantibody against retinal ganglion cells. Jpn J Ophthalmology 2000;44:648-52.
14. Yang J, Tezel G, Patil RV, et al. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest Ophthalmology Vis Sci 2001;42:1273-6.
15. Ikeda Y, Maruyama I, Nakazawa M, et al. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmology 2002;46:13-17.
16. Maruyama I, Maeda T, Okisaka S, et al. Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo. Jpn J Ophthalmology 2002;46:1-12.
17. Shokoohi KK, Shin DH, Elliott D, et al. Antiphospholipid antibodies in patients with normal tension glaucoma. Invest Ophthalmology Vis Sci 1999; 40 (Suppl) :342.
18. Sha'ban R, Asfour W, Kaabneh K. Ocularpseudoexfoliation associated with hearing loss. The 2nd International conference of Royal Jordanian Medical Services 2003; 300.